Leaving Community
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Blog
dkNET community events and announcements in November, 2017
Dear dkNET Community,
dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.
dkNET Updates:
- 2017 dkNET-NURSA Challenge Winner Announcement!
We are pleased to announce that the winner of our 2017 dkNET-NURSA Challenge is Dr. Kiely James. Congratulations, Kiely! Kiely will receive a $500 gift card, generously sponsored by SciCrunch! Thank you all again for participating in the dkNET-NURSA Challenge and dkNET Searchathon. Your submission was carefully reviewed by NURSA biocuration team, and we really appreciate your contributions to the scientific community. Twelve gift cards were given to the participants who completed the task and one grand prize ($500 gift card) was given to the winner.
- Call for beta testers!
We are currently beta testing our reproducibility reports for assist researchers to comply with NIH's requirements for rigor and reproducibility. If you have any suggestions/comments, please let us know. Please also contact us (info@dknet.org) if you are interested in being a beta tester.
Events in November, 2017
Nov. 1-2, 2017
Workshop on Immune System Engineering for Targeted Tolerance in Type 1 Diabetes (T1D)
This workshop will explore research on deactivating immune responses specifically and safely in T1D and other disease contexts. The workshop will also explore the prospects for engineering immune regulation in the context of autoimmune attack through the direct manipulation of regulatory and other cells for applications in cell therapy. Intervention based on targeting mechanisms of tolerance has the potential for novel therapeutic agents to prevent or treat the disease, including both immunomodulator
Location: North Bethesda, MD, USA
More information: https://www.niddk.nih.gov/news/events-calendar/Pages/TargetTolerance2017.aspx
Nov. 6-7, 2017
ERCC9 (Extracellular RNA Communication Consortium) semi-annual meeting
Since 2013, the Extracellular RNA Communication Consortium has been working to understand the biological functions of extracellular RNAs and vesicles in the healthy body and in disease, to identify biomarkers of disease that can be assayed from biofluids rather than through an invasive biopsy, and to develop therapies for disease using extracellular RNA and extracellular vesicles.The ERCC is pleased to announce that our next semi-annual meeting will be held on November 6-7, 2017 at the Hilton Washington DC / Rockville Hotel & Executive Meeting Center, Rockville, Maryland. Come join us to share your work and hear about the latest developments in the field. The meeting is open to anyone who is interested, and there is no cost for registration.Location: Washington, DC, USA
More information: http://exrna.org/ERCC9/
Nov. 6-7, 2017
Workshop: Using Patient-Reported Outcomes in Diabetes Research and Practice
To accelerate the standardized use of validated, generalizable, and standardized PRO measures in diabetes research and practice there is a need to harmonize efforts and identify the highest priority research gaps. To facilitate this area of research, the workshop will address these key topics and questions: Understanding PRO/HRQoL Measurement, Key Domains for measurement of PROs, Identify Research Needs and Gaps.
Location: Rockville, MD, USA
More information: https://www.niddk.nih.gov/news/events-calendar/Pages/using-patient-reported-outcomes-diabetes-research-practice.aspx
Nov. 7, 2017
Abstract Deadline: Keystone Symposium - Frontiers in Islet Biology and Diabetes (B3)
Location: Keystone, CO, USA
More information: http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1568
Nov, 8, 2017
ENDO2018 Abstract Submission Deadline
ENDO’s comprehensive program offers attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world. Join us at ENDO 2018 to get inspired by the experts so you can stay at the forefront of scientific discovery and high-quality patient care.
Location: Chicago, IL, USA
More information: https://www.endocrine.org/endo-2018/program
Nov. 16-17, 2017
Network of Minority Health Research Investigators West Regional Meeting
More than 300 researchers have participated in NMRI workshops in the past, and over 100 are active members. The success of the NMRI, a network that is "owned" by its members and supported by the NIDDK, begins with the dedication of senior investigators who mentor and serve as role models for junior investigators. The participation of active members and the recruitment of new members is a primary reason for the Network's success in the past and the reason for confidence that it will continue to grow in the future.
Location: Stanford, CA, USA
More information: https://www.niddk.nih.gov/news/events-calendar/Pages/nmri-15th-west-regional-meeting.aspx#tab-event-details
Nov. 18, 2017
19th Annual Frontiers in Diabetes Research Conference: Advances and Challenges in the Neuroscience of Ingestive Behaviors
More information: https://register.columbiacme.org/conference.cgi?rm=view&conference_id=826499
Nov. 28, 2017
Abstract Deadline: Keystone Symposia - Uncomplicating Diabetes: Reducing the Burden of Diabetes Related End-Organ Injury (J7)
Funding opportunities information and deadlines in November, 2017
Nov. 1, 2017
Funding Opportunity Application Due Date: Columbia University Medical Center Diabetes Research Center Pilot Feasibility Grants
The Columbia Diabetes Research Center (DRC) announces the availability of Pilot and Feasibility grants to support diabetes-relate
More information: https://www.derc.cumc.columbia.edu/pilot-feasibility-grant
Nov. 1, 2017
Funding Opportunity Application Deadline: Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)
The purpose of this Research Demonstration and Dissemination Projects (R18) Funding Opportunity Announcement (FOA) is to support research to evaluate large scale policies or programs related to healthcare delivery that are expected to influence diabetes prevention and care. This FOA is not intended to support the initiation and delivery of new policies or programs. Research support is for the evaluation of the effectiveness of healthcare programs and/or policies implemented independent of NIH grant funding. The goal is to support research that meaningfully informs clinical practice and health policy related to prevention or management of diabetes.
More information: https://grants.nih.gov/grants/guide/pa-files/PAR-17-178.html
Funding Opportunity Application deadline: Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage research applications to test innovative approaches to improve diabetes and obesity prevention and/or treatment that are adapted for implementation in healthcare settings where individuals receive their routine medical care. Research applications should be designed to test practical and sustainable strategies to improve processes of care and health outcomes for individuals with or at risk of diabetes and/or obesity. The research should also focus on approaches that can be broadly disseminated outside the specific setting where it is being tested. The goal of the research is to obtain results that will improve routine healthcare practice and inform healthcare policy for the prevention or management of these conditions. Therefore, interventions must be integrated into the existing healthcare structure and/or processes; the healthcare setting may not be used solely as a venue for recruitment.
More information: https://grants.nih.gov/grants/guide/pa-files/PAR-17-177.html
Nov. 1, 2017
Funding Opportunity Application Due Date: University Of Chicago Diabetes Research And Training Center Pilot And Feasibility Program
The Pilot and Feasibility (P and F) programs at the University of Chicago DRTC support new initiatives in diabetes related biomedical, epidemiological or behavioral research. The program is designed to provide limited support to develop preliminary data sufficient for funding of a research grant application or to test an innovative hypothesis which might have important implications or yield significant results for diabetes related research. Eligible investigators should hold a PhD, MD or MD/PhD degree and have a full time appointment at a research university or medical center in the Chicagoland area. Postdoctoral and MD Fellows are not eligible to appy, while faculty of paranthetical rank are eligible to apply. Applicants include new investigators without current or past NIH support as principal investigators, establish grant supported investigators who have not previously worked in diabetes related areas, or established investigators in diabetes related areas with a proposal for testing the feasibility of a new or innovative idea that is diabetes related and represents a clear and distinct departure from his/her ongoing research interests. The P and F programs at the University of Chicago provide a mechanism to foster the broad participation of investigators at various levels within the academic community and with highly varied training and experience in diabetes related research. Eligibility: University of Chicago Faculty.More information: http://drtc.bsd.uchicago.edu/pilot-feasibility/
Nov. 1, 2017
Funding Opportynity Application Due Date: George M. O'Brien Kidney Research Core Centers (P30)
This Funding Opportunity Announcement (FOA) invites applications for the George M. OBrien Kidney Research Centers to support both basic and clinical research on kidney disease. The goal of the O'Brien Kidney Research Center program is to make state-of-the art technologies and resources readily accessible to a broad spectrum of investigators pursuing studies in relevant topic areas. The emphases for this program are fourfold: (1) to attract new scientific expertise to and develop new tools for the study of human kidney physiology and disorders in humans and in animal and other models; (2) to encourage multidisciplina
More information: https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-17-005
Nov. 2, 2017
Funding Opportunity Application Due Date: Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)
This Funding Opportunity Announcement (FOA) invites applications for a Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54). The purpose of this Center is to: foster the study of individuals with rare/atypical forms of diabetes mellitus; identify and analyze phenotypic and genotypic defects that may provide insights into more common, heterogeneous forms of Type 2 diabetes mellitus (T2DM) in the general population; and develop a community resource to advance research in this area through the collection and dissemination of data and samples for access by the broad research community. To achieve this goal, the Center should support the following primary research endeavors: (1) develop a process for identifying and studying individuals/fam
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-006.html
Nov. 13, 2017
Keystone Symposia Scholarship Application Deadline: Uncomplicating Diabetes: Reducing the Burden of Diabetes-Related End-Organ Injury (J7)
Scientific Organizers: Mark E. Cooper, Thomas M. Coffman, Matthias G. von Herrath and Susan QuagginSymposia Dates: February 25—March 1, 2018
More information: http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1526
Nov. 17, 2017
Funding Opportunity Application Deadline: Melanoma Research Alliance (MRA) Awards For Young Investigators
Young Investigator Awards aim to attract early career scientists with novel ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma researcher leaders. Awardees will be provided up to $75,000 per year for 3 years to accomplish innovative, translational research projects. Eligibility: Applicants must be within 4 years of their first independent, full time academic faculty appointment at the time of application at the level of Assistant Professor (or equivalent position).
More information: http://www.curemelanoma.org/research/request-for-proposals/
Nov. 17, 2017
Funding Opportunity Application Deadline: Texas Medical Center Digestive Disease Center Pilot Project
The Texas Medical Center Digestive Diseases Center (DDC) announces the availability of grant funds to support pilot/feasibili
More information: https://www.bcm.edu/research/centers/digestive-disease/funding
Nov. 17, 2017
Funding Opportunity Application Deadline: Yale School Of Medicine Diabetes Research Center Feasibility Program
The DRC Pilot and Feasibility Study Award is intended to provide modest support that will allow an investigator the opportunity to develop sufficient preliminary data to provide the basis for an application for independent research support. Pilot and Feasibility Study support is not intended for large projects by established investigators which would otherwise be submitted as a separate research grant application. Pilot and feasibility funds are also not intended to support or supplement current ongoing funded research by an investigator. Eligibility: Yale Faculty at the time of appointment.
More information: http://derc.yale.edu/pilot/
Nov. 20, 2017
Letter of intent due date: Harvard University Digestive Disease Center Pilot And Feasibility Program
The HDDC is focused on the study of epithelial cell function and mucosal biology in inflammation, host defense, and cancer of the gastrointestina
More information: https://hddc.hms.harvard.edu/about
About
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant 2U24DK097771-09.
Contact Us
Email: info_at_ dknet.org
